NCT07171710
Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
The Ocular Surface Disease Index (OSDI) score
Timeframe: Assessed after 3 months of the trial
VAS score
Timeframe: Assessed after 3 months of the trial
BUT
Timeframe: Assessed after 6 months of the trial
tear river height
Timeframe: Assessed after 6 months of the trial
IVCM examination
Timeframe: Assessed after 6 months of the trial
Arms and interventions
Experimental groupOther
One eye was randomized to recieve a Smart plug absorbable lacrimal duct plugs, and cyclosporin A 0.05% cyclosporine A eye drops were administered three times daily to both eyes.
Control groupOther
cyclosporin A 0.05% cyclosporine A eye drops were administered three times daily to both eyes.
Drugs: 0.05% Cyclosporine Eye Drops
Devices: Smart plug absorbable lacrimal duct plugs
Sites
1 site in 1 country
- Tianjin Eye HospitalTianjin, Tianjin Municipality, China